Hematology CME

  • SAVE 15% W/ CODE: CME15

    Oakstone CME Thrombosis & Thromboembolism

    Learn Now: Thrombosis CME from the Experts

    This online CME course from the North American Thrombosis Forum provides a comprehensive review of the most significant changes and advances impacting the care of patients who have — or are at risk for — thrombotic disorders. World-renowned experts and leading clinical faculty share key updates on the prevention, diagnosis, and treatment of thrombosis and related conditions.

    Thrombosis and Thromboembolism is continuing medical education that will help you to:

    • Identify the etiology and pathophysiology of atherothrombosis
    • Recognize the link between inflammation and thrombotic illnesses
    • Explain new tools for stroke prevention and prediction in atrial fibrillation
    • Identify the optimal duration of anticoagulation for PE and DVT
    • Provide advanced therapies such as thrombolysis, catheter-directed therapy, and surgical embolectomy
    • Explain the connection between diabetes, metabolic syndrome, and major adverse cardiac events
    • Provide patients with useful insights into how a heart-healthy diet can help prevent thrombosis
    • Manage a high-risk pregnancy
    • And more…
    See full details chevron_right
    • Cost: $895
    • CME credits awarded by: Oakstone Publishing
    • Format: On-Demand Online
    • Material last updated: 12/31/2022
    • Expiration of CME credit: 12/31/2025
  • StatPearls Unlimited Physician MD/DO/PA CME

    Stay on top of your game with the StatPearls Physician Unlimited CME programs. With 6,046 activities, StatPearls is the largest CME provider in the world. These Pub-Med Indexed articles are categorized into 162 specialty areas which lets you better access activities that will make the biggest impact on your practice. One subscription allows access to all the activities, including all state-requirements.

    Pricing Options

    • 6 Month subscription: All 6,339 CME Activities $249 per 6 months
    • Annual subscription: All 6,339 CME Activities $349 per 1 year
    • Lifetime: All 6,339 CME Activities + Access to Board Reviews Forever $1999
    See full details chevron_right
    • Cost: Varies
    • CME credits awarded by: ETSU
    • Format: On Demand Online & Board Reviews
  • FEATURED

    BoardVitals Hematology and Oncology CME Board Review

    The BoardVitals Hematology and Oncology CME Review offers clinicians 27 AMA PRA Category 1 CreditsTM, 27 ABIM MOC points, and over 500 Hematology and Oncology board review questions. The questions cover key topics including Breast Cancer, Gynecologic Cancer, and Transfusion Medicine. This question bank will assist clinicians with Hematology and Oncology certification and recertification.

    The BoardVitals Hematology and Oncology CME Review also features:

    • Quick and Convenient CME
    • Computer, phone, and tablet access
    • Constantly updated up-to-date questions
    • Questions that are targeted specifically to the exam
    • Online CME tracker
    • 100% Pass Guarantee
    • Statistical comparison to other Hematology and Oncology test-takers (Nationally)

     

    After completing this activity, you should be able to:

    • Make a diagnosis
    • Order and interpret results
    • Assess risk, determine prognosis, and apply principles from epidemiologic studies
    • Describe the underlying pathophysiology of disease and basic science knowledge

     

    Target Audience: Hematologists and Oncologists

    See full details chevron_right
    • Cost: $599
    • Credit hours: 27
    • CME credits awarded by: BoardVitals
    • Format: On-Demand Online
    • Material last updated: Continuously Updated
  • Oakstone MKSAP® 19 Audio Companion

    Expert Advice and Insightful Commentary

    The MKSAP® 19 Audio Companion sheds light on the latest diagnostic approaches, management strategies, and treatment guidelines. In this comprehensive audio CME program, you’ll join host Donald L. Deye, MD, FACP, as he leads lively discussions with esteemed colleagues in 11 internal medicine subspecialties. Listen as experienced clinicians from some of the world’s finest medical institutions share patient stories, insightful views of recent clinical advances, and more.

    Anytime, Anywhere Audio CME

    With the MKSAP 19 Audio Companion, you get:

    • All-new advice and commentary — a reliable, and entertaining way to learn current oncology trends, the latest approaches to diabetes treatment, COVID updates, new tactics for managing patients with COPD, and so much more
    • An easy way to prep for your ABIM certification or MOC exam
    • Flexible learning to fit your schedule — in your car, between appointments, while you work out
    • Companion booklets — high-impact PDF learning aids to quickly review and retain key points (print booklets available for an additional charge)
    • The opportunity to earn AMA PRA Category 1 Credits and ABIM MOC points
    • Four FREE sets of extension questions — a $350 value that brings you incremental AMA PRA Category 1 Credits™ and MOC points

    Audience

    General internists and primary care physicians; subspecialists who need to remain up to date in internal medicine; residents preparing for the certifying examination in internal medicine; physicians preparing for the recertification examination. 

    Learning Objectives

    • Discuss the most clinically relevant patient care information in all subspecialties of Internal Medicine based on the medical literature of the last 3 to 5 years
    • Describe clinical situations in which this new knowledge will improve quality of care
    • Diagnose disease states that are less common and sometimes overlooked and confusing
    • Determine when to refer patients for surgery or care by subspecialists
    See full details chevron_right
    • Cost: $1297
    • CME credits awarded by: Oakstone Publishing, LLC
    • Format: On-Demand Online, Online Audio, Audio CD
    • Material last updated: Part A Release: August 31, 2021 Part B Release: January 31, 2022
    • Expiration of CME credit: Expiration Date: August 31, 2024 Expiration Date: December 31, 2024
  • SAVE 15% W/ CODE: CME15

    Oakstone CME The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology

    Elevate Your Hematology and Oncology CME

    The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology is a case-based online CME course focused on improving overall knowledge and clinical competency. Prep for your board exam and stay current on basic principles, changing guidelines and therapeutic strategies. Practice improvement areas featured in the continuing medical education program include:

    • Acquired/Congenital Bone Marrow Failure
    • Thalassemia/Hemoglobinopathies
    • Transfusion Medicine
    • New Therapies (Pharmacology)
    • Infections of the Immunocompromised
    • Hematologic Malignancies (Acute/Chronic Leukemias; Myeloma/Lymphomas)
    • Thoracic Oncology (Head/Neck/Lung/Thyroid)
    • and many more…
    See full details chevron_right
    • Cost: $1795
    • Credit hours: 41.25
    • CME credits awarded by: Oakstone Publishing
    • Format: Online, On Demand, USB
    • Material last updated: June 30, 2022
    • Expiration of CME credit: June 30, 2025
  • SAVE 15% W/ CODE: CME15

    Oakstone CME The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology

    Elevate Your Hematology CME

    The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology online CME program brings together a distinguished group of experts to present current diagnostic and therapeutic strategies. Enhance patient care and prep for your board exam with topics like molecular genetics, leukemia, bone marrow failures, transfusion medicine, and more. It’s continuing medical education that will help you to better:

    • Apply current/recommended hematology guidelines in clinical practice
    • Perform differential diagnosis of complex hematologic disorders
    • Identify and apply current therapeutic options for hematologic disorders
    • Evaluate and interpret up-to-date literature relevant to clinical practice in hematology
    • Illustrate knowledge of pathophysiology of hematology disorders
    • Apply knowledge gained to the ABIM certification/recertification

    This program is also available as part of the combined Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology CME course found here.

    See full details chevron_right
    • Cost: $1295
    • Credit hours: 24
    • CME credits awarded by: Oakstone Publishing
    • Format: On-Demand Online, Online Video, Online Audio, Audio CD
    • Material last updated: July 15, 2022
    • Expiration of CME credit: July 15, 2025
  • MedCram 3 year All Access CME Pass

    Medical videos & lectures explained clearly by world-class instructors.

    Memorable illustrations, clinical scenarios, and passionate instructors set MedCram apart from other online medical lectures.

    We prioritize the most important clinically relevant and practical information for clinical practice.

    Understanding medicine has never been so simplified.

    See full details chevron_right
    • Cost: $495
    • Credit hours: 46.75
    • CME credits awarded by: ACCME
    • Format: Medical education videos available on demand
    • Material last updated: Continuously Updated
  • FREE

    ScientiaCME Hematology/Oncology

    Target Audience: Hematologists

    See full details chevron_right
    • Cost: Free
    • Credit hours: 7.25
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Expiration of CME credit: Two years after release
  • FREE

    CME: von Willebrand’s Disease (vWB): Therapeutic Updates and Optimizing Treatment

    In this online, self-learning activity:

    Von Willebrand disease (vWD) is the most common congenital bleeding disorder worldwide. Affecting both male and female births in equal number, vWD is caused by a deficiency or defect in the von Willebrand factor (vWF) glycoprotein, which is responsible for mediating platelet and coagulation factor VIII function. vWD types 1 and 3 are caused by quantitative deficiencies in vWF. In contrast, type 2 vWD is caused by a qualitative defect in the production of vWF. Type 1 is the most common type of vWD, accounting for 60% to 70% of cases, followed by type 2, which is diagnosed in 25% to 30% of patients. Type 3 vWD, the rarest form, affects about 1 in 1,000,000 people. There is evidence that the use of factor VIII/vWF concentrates should be individualized, but no recent vWD guidelines address this issue. Although DDAVP is the treatment of choice for most type 1 vWD patients, data do not support the use of DDAVP for type 2B vWD owing in part to an increased risk for thrombocytopenia. Another practice gap is a lack of guidance around the appropriate ages at which patients with severe vWD are optimally initiated on vWF prophylaxis. Furthermore, although DDAVP is not contraindicated in pregnancy, 31% of physicians consider DDAVP a contraindication according to the results of one survey, illustrating a present area of controversy in practice.

    Target Audience:

    The following healthcare professionals: Hematologists and primary care physicians; physician assistants, nurse practitioners, and pharmacists who practice in hematology; and any other healthcare professionals with an interest in or who clinically encounter patients with vWD.

    See full details chevron_right
    • Cost: Free
    • CME credits awarded by: 1
    • Format: On-Demand Online
    • Material last updated: March 07, 2021
    • Expiration of CME credit: March 07, 2023
  • FREE

    Treating Oncology Patients During COVID-19

    Activity Description / Statement of Need: The COVID-19 pandemic has led to unprecedented changes in health care delivery worldwide, affecting the way that nearly every medical specialty can safely practice. As with other fields of medicine, oncology has its own challenges in navigating the pandemic. Based on pre-pandemic estimates, 1.8 million new cancer diagnoses would be expected in 2020, equating to approximately 5,000 new cancer diagnoses per day. Evidence thus far suggests that COVID-19 is associated with significantly more complications and a higher risk of death in patients with cancer or with a history of cancer. Furthermore, patients with cancer have also been shown to have a higher COVID-19 infection rate than the general population, suggesting increased susceptibility, potentially due to immunosuppression, comorbidities, or poor health status related to cancer or its treatment. Based on these data, oncology specialists are said to be fighting “a war on two fronts” by balancing the risks of COVID-19 transmission and acquisition with the risks of delayed cancer diagnosis and treatment. This represents an unmet need among oncology practitioners as they navigate this new health care landscape.

    Target Audience:

    Healthcare professionals, including medical oncologists; radiation oncologists; surgical oncologists; surgeons; radiologists; nuclear medicine specialists; nurse practitioners and physician assistants who practice in oncology; and other healthcare providers who manage cancer.

    By the end of the session the participant will be able to:

    • Recall the symptoms of COVID-19 infection and best practices for screening patients, health care providers, and staff in the oncology setting.
    • Develop a plan to provide oncology care in the setting of the COVID-19 pandemic.
    • Describe the risks of delaying cancer diagnosis and treatment against the risk of COVID-19 exposure and infection.
    • See full details chevron_right
    • Cost: Free
    • Credit hours: .75
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 09/22/2020
    • Expiration of CME credit: 09/22/2022